Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00169234 · ClinicalTrials.gov registry record · Phase 1
Pneumococcal Adult-dose Ranging Immunization Study
A Phase 1 study of Pneumonia, sponsored by Kaiser Permanente.
- Completed
- Registry status
- Phase 1
- Development phase
- 220
- Enrollment target
- 2
- Study locations
NCT00169234: Completed Phase 1 study of Pneumonia, sponsored by Kaiser Permanente.
NCT00169234 is a Phase 1 study of Pneumonia that has completed, run by Kaiser Permanente. The registered enrollment target is 220 participants, below the 4,515-participant average among 47 other Pneumonia trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00169234, a Phase 1 study of Pneumonia, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 220 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to give seniors different doses of a new pneumococcal vaccine called PCV7 to evaluate the safety of the vaccine and compare the immune response to find out which amount gives the best immune response. The PCV7 vaccine is currently licensed by the FDA for use in infants and toddlers only.
Conditions Studied
Interventions
- BIOLOGICAL PCV7, Prevnar®
- BIOLOGICAL Pneumovax 23
Study Locations (2)
Washington
- Group Health Research Institute - Seattle
- VA Puget Sound Health Care System - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2003-05 |
| Est. Completion | 2005-02 |
| Phase | Phase 1 |
What the finished NCT00169234 record still lists
NCT00169234 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 4,515-participant average among 47 other Pneumonia trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Pneumonia appearing as the primary indexed condition, and to 2 interventions - of which PCV7, Prevnar® is the first listed.
NCT00169234 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT00169234 about?
NCT00169234 is a clinical study titled "Pneumococcal Adult-dose Ranging Immunization Study". The purpose of this study is to give seniors different doses of a new pneumococcal vaccine called PCV7 to evaluate the safety of the vaccine and compare the immune response to find out which amount gives the best immune response. The PCV7 vaccine is currently licensed by the FDA for use in infants a...
What is the current status of trial NCT00169234?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 220 participants. The study started on 2003-05. Estimated completion is 2005-02.
What conditions does trial NCT00169234 study?
This clinical trial studies the following conditions: Pneumonia.
What interventions are being tested in trial NCT00169234?
The interventions under investigation include: PCV7, Prevnar® (BIOLOGICAL), Pneumovax 23 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00169234?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00169234 being conducted?
This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pneumonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00169234's enrollment target sits among peer trials
220 20th of 47 higher than 28 of 47 other Pneumonia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pneumonia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271
COMPLETED · Phase 1
-
Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections
COMPLETED · Phase 1
-
PET Imaging of Endotoxin-induced iNOS Activation
COMPLETED · Phase 1
-
The APS Phenotyping Study
RECRUITING
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
Extending Dental Care to Nursing Home Residents to Reduce Mouth Infections and Incidence of Pneumonia and Improve Diabetic Glucose Control
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia